Anne Li 6/9/17
|
In a paper published in the journal Pain, Saint Louis University researcher Daniela Salvemini, Ph.D., reports discovering a key molecular pathway that drives cancer-related bone pain while providing a potential solution with a drug that already is on the market. Salvemini, who is a professor of pharmacology and physiology at SLU, studies many sorts of pain, including chronic pain, cancer pain and chemotherapy-induced pain, in search of new treatments. "Pain is a huge problem — for the patient, the caregiver, the family, the doctors," Salvemini said. "We have limited options. "So, I have a sense of urgency — I don't want people to be in pain — and therefore I have made it my mission to discover drugs that can effectively abrogate pain."
See original article at: https://www.sciencedaily.com/releases/2017/06/170607222417.htm |